Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of Medicinal Chemistry|March 1, 1991
A highly specific aldose reductase inhibitor, ethyl 1-benzyl-3-hydroxy-2(5H)-oxopyrrole-4-carboxylate, and its congenersB L Mylari, T A Beyer, T W SiegelLife Sciences|January 1, 1991
The role of polyols in cerebral cell volume regulation in hypernatremic and hyponatremic statesH Trachtman, S Futterweit, E Hammer, et al.The Journal of Biological Chemistry|September 10, 1981
Purification and properties of the human placental insulin receptorT W Siegel, S Ganguly, S Jacobs, et al.Journal of Medicinal Chemistry|June 12, 1992
Orally active aldose reductase inhibitors: indazoleacetic, oxopyridazineacetic, and oxopyridopyridazineacetic acid derivativesB L Mylari, W J Zembrowski, T A Beyer, et al.Journal of Medicinal Chemistry|July 1, 1990
Spiro hydantoin aldose reductase inhibitors derived from 8-aza-4-chromanonesR Sarges, S W Goldstein, W M Welch, et al.Proceedings of the National Academy of Sciences of the United States of America|October 1, 1981
Genetic control of insulin receptorsA E Goldfeld, C S Rubin, T W Siegel, et al.Journal of Medicinal Chemistry|February 7, 1992
Potent, orally active aldose reductase inhibitors related to zopolrestat: surrogates for benzothiazole side chainB L Mylari, T A Beyer, P J Scott, et al.Journal of Medicinal Chemistry|June 12, 1992
Hydantoin bioisosteres. In vivo active spiro hydroxy acetic acid aldose reductase inhibitorsC A Lipinski, C E Aldinger, T A Beyer, et al.Journal of Medicinal Chemistry|January 1, 1991
Novel, potent aldose reductase inhibitors: 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl] methyl]-1-phthalazineacetic acid (zopolrestat) and congenersB L Mylari, E R Larson, T A Beyer, et al.Bioorganic & Medicinal Chemistry Letters|October 10, 2001
Small molecule somatostatin receptor subtype-2 antagonistsB A Hay, B M Cole, F M DiCapua, et al.Pageof 1